IP Library Granted Patent US 12,311,368
Granted Patent B2
US 12,311,368 · App. 17/211,277 · Granted May 27, 2025

Biological fluid filtration system

Inventor: Jayant Parthasarathy (Excelsior, MN)
Assignee: Astrin Biosciences, Inc.
B01L3/502753B01D46/0013B01D46/0028B01D46/2414B01D46/522B01D46/64B01D46/70B01D53/78B01L3/502715B01L2300/0654B01L2300/0681
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,311,368
App. No.
17/211,277
Granted
May 27, 2025
Kind
B2
Abstract

A biological fluid filtration system for scanning a biological fluid so as to filter potentially undesirable constituents from the biological fluid for therapeutic or diagnostic purposes. The biological fluid filtration system generally includes a fluid receiving device adapted to receive a biological fluid. A valve including an inlet, a first outlet, and a second outlet is fluidly connected to the fluid receiving device. The biological fluid within the fluid receiving device is scanned by a scanner to produce scanned data relating to the biological fluid. A control unit in communication with the scanner and the valve receives the scanned data and controls the valve based on the scanned data. The valve is controlled to direct the biological fluid through either the first or second outlet of the valve depending upon the constituents of the biological fluid identified by the control unit.

Claims (17)

1. A biological fluid filtration system, comprising:

a fluid receiving device adapted to receive a biological fluid;

a valve comprising an inlet, a first outlet, and a second outlet, wherein the inlet of the valve is fluidly connected to the fluid receiving device;

a scanner configured to scan the biological fluid within the fluid receiving device to produce a scanned data relating to the biological fluid within the fluid receiving device; wherein the scanner is an optical scanner comprising a digital holographic microscope; and

a control unit in communication with the scanner and the valve, wherein the control unit is configured to receive the scanned data from the scanner, wherein the control unit is configured to compare the scanned data to a reference data, wherein the reference data comprises one or more characteristics of healthy cell types other than a selected healthy cell type subset, wherein the healthy cell type subset is comprised of a white blood cell, and wherein the control unit is configured to control the valve based on the scanned data from the scanner;

wherein the control unit is configured to control the valve to (a) direct the biological fluid through the first outlet if the control unit determines that the scanned data indicates a presence of the healthy cell types within the biological fluid or (b) direct the biological fluid through the second outlet if the control unit determines that the scanned data does not indicate the presence of the healthy cell types within the biological fluid, such that the selected healthy cell type subset is directed through the second outlet.

2. The biological fluid filtration system of claim 1 , wherein the healthy cell type subset is comprised of a natural killer cell.

3. The biological fluid filtration system of claim 1 , wherein the healthy cell type subset is comprised of a macrophage.

4. The biological fluid filtration system of claim 1 , wherein the biological fluid is comprised of a leukapheresis extract.

5. A method of filtering a biological fluid using the biological fluid filtration system of claim 1 , comprising the steps of: receiving the biological fluid by the fluid receiving device; scanning the biological fluid within the fluid receiving device by the scanner; comparing the scanned data with the reference data by the control unit; directing the biological fluid through the first outlet if the control unit determines that the scanned data indicates the presence of the healthy cell types within the biological fluid; and directing the biological fluid through the second outlet if the control unit determines that the scanned data does not indicate the presence of the healthy cell types within the biological fluid.

6. A biological fluid filtration system, comprising:

a fluid receiving device adapted to receive a biological fluid;

a valve comprising an inlet, a first outlet, and a second outlet, wherein the inlet of the valve is fluidly connected to the fluid receiving device;

a scanner configured to scan the biological fluid within the fluid receiving device to produce a scanned data relating to the biological fluid within the fluid receiving device; wherein the scanner is an optical scanner comprising a digital holographic microscope; and

a control unit in communication with the scanner and the valve, wherein the control unit is configured to receive the scanned data from the scanner, wherein the control unit is configured to compare the scanned data to a reference data, wherein the reference data comprises one or more characteristics of healthy cell types other than a selected healthy cell type subset, wherein the healthy cell type subset is comprised of a T-cell, and wherein the control unit is configured to control the valve based on the scanned data from the scanner; wherein the control unit is configured to control the valve to (a) direct the biological fluid through the first outlet if the control unit determines that the scanned data indicates a presence of the healthy cell types within the biological fluid or (b) direct the biological fluid through the second outlet if the control unit determines that the scanned data does not indicate the presence of the healthy cell types within the biological fluid, such that the selected healthy cell type subset is directed through the second outlet.

7. The biological fluid filtration system of claim 6 , wherein the biological fluid is comprised of a leukapheresis extract.

8. A method of filtering a biological fluid using the biological fluid filtration system of claim 6 , comprising the steps of: receiving the biological fluid by the fluid receiving device; scanning the biological fluid within the fluid receiving device by the scanner; comparing the scanned data with the reference data by the control unit; directing the biological fluid through the first outlet if the control unit determines that the scanned data indicates the presence of the heathy cell types within the biological fluid; and directing the biological fluid through the second outlet if the control unit determines that the scanned data does not indicate the presence of the healthy cell types within the biological fluid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2025
From: PARTHASARATHY, JAYANT
To: ASTRIN BIOSCIENCES, INC.
Reel/Frame 070788/0429 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2021
From: PARTHASARATHY, JAYANT, MR.
To: ASTRIN BIOSCIENCES,INC.
Reel/Frame 055708/0692 →
Continuity (3)
Continuation 17162450 · Jan 29, 2021
Provisional Application 62968476 · Jan 31, 2020
Related Publication 20210237075A1 · Aug 5, 2021
References Cited (151)
US 5316725A · Carver, Jr. et al. · 1994 [cited by applicant]
US 5628727A · Hakky et al. · 1997 [cited by applicant]
US 8241238B2 · Hiruma · 2012 [cited by applicant]
US 8548219B2 · Ortyn · 2013 [cited by applicant]
US 9422517B2 · Chen · 2016 [cited by applicant]
US 9458489B2 · Lim · 2016 [cited by applicant]
US 9545471B2 · van Rijn · 2017 [cited by applicant]
US 9808803B2 · Toner · 2017 [cited by applicant]
US 10073024B2 · Nagrath · 2018 [cited by applicant]
US 10147180B2 · Couch et al. · 2018 [cited by applicant]
US 10386384B2 · Hong · 2019 [cited by applicant]
US 10407180B2 · Morellec et al. · 2019 [cited by applicant]
US 10519175B2 · Londesbrough et al. · 2019 [cited by applicant]
US 12162010B2 · Parthasarathy et al. · 2024 [cited by applicant]
US 20020005354A1 · Spence · 2002 [cited by examiner]
US 20020033939A1 · Hansen · 2002 [cited by applicant]
US 20020058332A1 · Quake et al. · 2002 [cited by applicant]
US 20020182738A1 · Connelly et al. · 2002 [cited by applicant]
US 20030198523A1 · Bohm et al. · 2003 [cited by applicant]
US 20040072278A1 · Chou · 2004 [cited by applicant]
US 20040161143A1 · Dietz · 2004 [cited by applicant]
US 20050142570A1 · Parthasarathy et al. · 2005 [cited by applicant]
US 20050221271A1 · Murphy · 2005 [cited by applicant]
US 20050255001A1 · Padmanabhan et al. · 2005 [cited by applicant]
US 20070054350A1 · Walker · 2007 [cited by applicant]
US 20070286254A1 · Fon et al. · 2007 [cited by applicant]
US 20080038713A1 · Gao et al. · 2008 [cited by applicant]
US 20080213821A1 · Liu et al. · 2008 [cited by applicant]
US 20080248499A1 · Chiu · 2008 [cited by applicant]
US 20080261295A1 · Bulter et al. · 2008 [cited by applicant]
US 20090198168A1 · Hiruma · 2009 [cited by examiner]
US 20110003325A1 · Durack · 2011 [cited by applicant]
US 20110217729A1 · Hong et al. · 2011 [cited by applicant]
US 20120021453A1 · Patra · 2012 [cited by applicant]
US 20120129190A1 · Chiu et al. · 2012 [cited by applicant]
US 20120264646A1 · Link · 2012 [cited by applicant]
US 20130011210A1 · Toner et al. · 2013 [cited by applicant]
US 20130171685A1 · Schutze et al. · 2013 [cited by applicant]
US 20130190202A1 · Southern · 2013 [cited by applicant]
US 20130314526A1 · Yasuda et al. · 2013 [cited by applicant]
US 20140074008A1 · Fontanazzi et al. · 2014 [cited by applicant]
US 20140170735A1 · Holmes · 2014 [cited by applicant]
US 20140190888A1 · van Rijn · 2014 [cited by applicant]
US 20140248621A1 · Collins et al. · 2014 [cited by applicant]
US 20140376816A1 · Lagae · 2014 [cited by examiner]
US 20150118728A1 · Rahman · 2015 [cited by applicant]
US 20150132766A1 · Yasuda · 2015 [cited by applicant]
US 20150238963A1 · Han et al. · 2015 [cited by applicant]
US 20160032350A1 · Hou et al. · 2016 [cited by applicant]
US 20160084814A1 · Olson et al. · 2016 [cited by applicant]
US 20160106353A1 · Schuetz et al. · 2016 [cited by applicant]
US 20160146823A1 · Chiu · 2016 [cited by applicant]
US 20160231274A1 · Tirapu Azpiroz et al. · 2016 [cited by applicant]
US 20160340636A1 · Tabata · 2016 [cited by applicant]
US 20160349232A1 · Shults et al. · 2016 [cited by applicant]
US 20170003267A1 · Meyer et al. · 2017 [cited by applicant]
US 20170080142A1 · Biran · 2017 [cited by applicant]
US 20170122861A1 · Lin · 2017 [cited by applicant]
US 20170212033A1 · Ozaki · 2017 [cited by applicant]
US 20170248508A1 · Ward et al. · 2017 [cited by applicant]
US 20170327783A1 · Grummitt · 2017 [cited by applicant]
US 20170368373A1 · Sahadevan · 2017 [cited by applicant]
US 20180104691A1 · Merten et al. · 2018 [cited by applicant]
US 20180128723A1 · Ryu et al. · 2018 [cited by applicant]
US 20180154361A1 · Foster et al. · 2018 [cited by applicant]
US 20180297085A1 · Deshpande et al. · 2018 [cited by applicant]
US 20180313816A1 · Fiering et al. · 2018 [cited by applicant]
US 20180321128A1 · Harriman · 2018 [cited by applicant]
US 20180334670A1 · Bharadwaj et al. · 2018 [cited by applicant]
US 20190022652A1 · Xie et al. · 2019 [cited by applicant]
US 20190151847A1 · Bhagat · 2019 [cited by applicant]
US 20190195774A1 · El-Zehiry et al. · 2019 [cited by applicant]
US 20190300928A1 · Krishnamurthy et al. · 2019 [cited by applicant]
US 20190332054A1 · Hong · 2019 [cited by applicant]
US 20190360915A1 · Foster · 2019 [cited by applicant]
US 20190369557A1 · Lee et al. · 2019 [cited by applicant]
US 20200206740A1 · Chiu et al. · 2020 [cited by applicant]
US 20200222905A1 · Hill et al. · 2020 [cited by applicant]
US 20200376488A1 · Wu et al. · 2020 [cited by applicant]
US 20210172950A1 · Toner et al. · 2021 [cited by applicant]
US 20210196767A1 · Minami et al. · 2021 [cited by applicant]
US 20210237064A1 · Parthasarathy · 2021 [cited by applicant]
US 20210237065A1 · Parthasarathy · 2021 [cited by applicant]
US 20210237066A1 · Parthasarathy · 2021 [cited by applicant]
US 20210237067A1 · Parthasarathy · 2021 [cited by applicant]
US 20210237068A1 · Parthasarathy · 2021 [cited by applicant]
US 20210237069A1 · Parthasarathy · 2021 [cited by applicant]
US 20210237070A1 · Parthasarathy · 2021 [cited by applicant]
US 20210237071A1 · Parthasarathy · 2021 [cited by applicant]
US 20210237072A1 · Parthasarathy · 2021 [cited by applicant]
US 20210237073A1 · Parthasarathy · 2021 [cited by applicant]
US 20210237074A1 · Parthasarathy · 2021 [cited by applicant]
US 20210237075A1 · Parthasarathy · 2021 [cited by applicant]
US 20210237076A1 · Parthasarathy · 2021 [cited by applicant]
US 20210252512A1 · Parthasarathy · 2021 [cited by applicant]
US 20210252513A1 · Parthasarathy · 2021 [cited by applicant]
US 20210346584A1 · Lee et al. · 2021 [cited by applicant]
US 20220088041A1 · Londesbrough et al. · 2022 [cited by applicant]
US 20220409584A1 · Bilal et al. · 2022 [cited by applicant]
US 20230033651A1 · Toner et al. · 2023 [cited by applicant]
CN 101629909B · 2012 [cited by examiner]
EP 1281951A1 · 2003 [cited by examiner]
EP 1190229B1 · 2011 [cited by applicant]
EP 2902108A1 · 2015 [cited by applicant]
WO WO1999061888A2 · 1999 [cited by applicant]
WO WO1999061888A3 · 1999 [cited by applicant]
WO 2009051734A1 · 2009 [cited by applicant]
WO WO2013085797A1 · 2013 [cited by applicant]
WO WO2017034517A1 · 2017 [cited by applicant]
WO WO2018035262A1 · 2017 [cited by applicant]
WO 2017189899A1 · 2017 [cited by applicant]
WO 2018020285A2 · 2018 [cited by applicant]
WO WO2018237239A1 · 2018 [cited by applicant]
WO 2019035952A1 · 2019 [cited by applicant]
WO WO2019040599A1 · 2019 [cited by applicant]
WO WO2019189408A1 · 2019 [cited by applicant]
WO WO2019195934A1 · 2019 [cited by applicant]
WO WO2019204333A1 · 2019 [cited by applicant]
WO WO2019204854A1 · 2019 [cited by applicant]
https://bmccancer.biomedcentral.com/track/pdf/10.1186/1471-2407-13-283.pdf; “Detection of Cancer Before Distant Metastasis” Article; Leon WMM Terstappen et al.; BMC Cancer; Published Jun. 13, 2013. [cited by applicant]
https://www.nature.com/articles/s41408-020-0320-7.pdf; ““Direct to Drug” Screening as a Precision Medicine Tool in Multiple Myeloma” Article; Cecilia Bonolo de Campos et al.; Blood Cancer Journal; Published May 11, 2020. [cited by applicant]
https://www.mdpi.com/1422-0067/21/13/4813/pdf; “A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer” Articl… [cited by applicant]
https://www.mdpi.com/2072-6694/12/3/743/pdf; “Gauging the Impact of Cancer Treatment Modalities on Circulating Tumor Cells (CTCs)” Article; Michele I. Vitolo et. al.; Cancers Journal; Mar. 21, 2020. [cited by applicant]
https://www.pnas.org/content/pnas/117/29/16839.full.pdf; “Ultrahigh-Throughput Magnetic Sorting of Large Blood Volumes for Epitope-Agnostic Isolation of Circulating Tumor Cells” Article; Daniel A. Haber et. al.; PNAS; M… [cited by applicant]
https://wjso.biomedcentral.com/track/pdf/10.1186/1477-7819-11-159.pdf; “Extracorporeal Tumor Cell Filtration during Extended Liver Surgery: First Clinical use of Leukocyte Depletion Filters—a Case Series” Article; Nils … [cited by applicant]
https://clincancerres.aacrjournals.org/content/clincanres/24/22/5635.full-text.pdf; “Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis” Article; Johann S. de Bono et. al.; AACR Publications; … [cited by applicant]
https://www.nature.com/articles/s41467-019-09439-9.pdf; “A Temporary Indwelling Intravascular Aphaeretic System for In Vivo Enrichment of Circulating Tumor Cells” Article; Sunitha Nagrath et. al.; Nature Communications;… [cited by applicant]
https://academic.oup.com/noa/article-pdf/2/1/vdaa052/33236713/vdaa052.pdf; “Evaluation of Neurapheresis Therapy In Vitro: a Novel Approach for the Treatment of Leptomeningeal Metastases” Article; Shivanand P. Lad et. al… [cited by applicant]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486079/pdf/nihms-702225.pdf; “The CTC-Chip: An Exciting New Tool to Detect Circulating Tumor Cells in Lung Cancer Patients” Article; Sunitha Nagrath, PhD et al.; J Thorac On… [cited by applicant]
https://aip.scitation.org/doi/pdf/10.1063/1.5120501; “Label-Free Microfluidic Sorting of Microparticles” Article; Ian Papautsky et. al.; APL Bioengineering; Dec. 11, 2019. [cited by applicant]
https://onlinelibrary.wiley.com/doi/epdf/10.1002/cyto.a.23100; “Quantitative Phase Microscopy Spatial Signatures of Cancer Cells” Article; Darina Roitshtain et. al.; Submitted to Cytometry Part A; Wiley Online Library; … [cited by applicant]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261517/pdf/nihms982306.pdf; “An Intravascular Magnetic Wire for the High-Throughput Retrieval of Circulating Tumour Cells In Vivo” Article; Sanjiv S. Gambhir et. al.; Nat Bi… [cited by applicant]
PCT International Search Report and Written Opinion for PCT Application PCT/US2021/015945; Apr. 21, 2021. [cited by applicant]
Extended European Search Report for European Patent Application No. 21748010.2, mailed Jan. 30, 2024. [cited by applicant]
U.S. Appl. No. 17/162,450 2021/0237064, filed Jan. 29, 2021 Aug. 5. 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
U.S. Appl. No. 17/205,338 2021/0237066, filed Mar. 18, 2021 Aug. 5, 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
U.S. Appl. No. 17/205,393 2021/0237067, filed Mar. 18, 2021 Aug. 5, 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
U.S. Appl. No. 17/205,508 2021/0237068, filed Mar. 18, 2021 Aug. 5, 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
U.S. Appl. No. 17/205,595 2021/0237069, filed Mar. 18, 2021 Aug. 5, 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
U.S. Appl. No. 17/205,171 2021/0237065, filed Mar. 18, 2021 Aug. 5, 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
U.S. Appl. No. 17/205,769 2021/0237070, filed Mar. 18, 2021 Aug. 5, 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
U.S. Appl. No. 17/206,405 2021/0237073, filed Mar. 19, 2021 Aug. 5, 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
U.S. Appl. No. 17/206,471 2021/0237074, filed Mar. 19, 2021 Aug. 5, 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
U.S. Appl. No. 17/206,231 2021/0237071, filed Mar. 19, 2021 Aug. 5, 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
U.S. Appl. No. 17/206,271 2021/0237072, filed Mar. 19, 2021 Aug. 5, 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
U.S. Appl. No. 17/211,373 2021/0237076, filed Mar. 24, 2021 Aug. 5, 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
U.S. Appl. No. 17/211,277 2021/0237075, filed Mar. 24, 2021 Aug. 5, 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
U.S. Appl. No. 17/313,421 2021/0252513, filed May 6, 2021 Aug. 5, 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
U.S. Appl. No. 17/313,369 2021/0252512, filed May 6, 2021 Aug. 29, 2021, Jayant Parthasarathy, Biological Fluid Filtration System. [cited by applicant]
Gambro BCT, “COBE® Spectra Aphoresis System Essentials Guide”, Mar. 2005. [cited by applicant]
Sharma et al., “Circulating Tumor Cell Isolation, Culture, and Downstream Molecular Analysis”, Biotechnol Adv., Jul.-Aug. 2018, 36(4): 1063-1078. [cited by applicant]